Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;105(6):1115-8.
doi: 10.1160/TH10-09-0628. Epub 2011 Apr 7.

Phospholipid binding lowers immunogenicity of human recombinant factor VIII in von Willebrand factor knockout mice

Phospholipid binding lowers immunogenicity of human recombinant factor VIII in von Willebrand factor knockout mice

D S Pisal et al. Thromb Haemost. 2011 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of PI and PS on immunogenicity of FVIII. A) The mean of total antibody titers (bars) and individual (closed circles) antibody titers against FVIII as determined by antibody capture ELISA in vWF mice immunized via i.v. administration of free FVIII, FVIII-PI, and FVIII-PS. B) The mean of inhibitory titers (bars) and individual (closed circles) antibody titers against FVIII as determined by the Nijmegen modification of the Bethesda assay in vWF knockout mice immunized via i.v. administration of free FVIII, FVIII-PI, FVIII-PS. C) Left panel shows the raw data for Thymidine (3H) incorporation (counts per minute) of different groups of splenocytes. The mean count (cross) and splenocytes from individual spleen (n=6) are shown (filled triangles). Typically negative group showed counts less than 300. Right panel shows the stimulation indices of different groups of splenocytes. The mean stimulation index (cross) and individual (filled circles) stimulation indices from individual spleens (n=6) of different treatment groups as determined by thymidine (3H) incorporation T cell proliferation assay.
Figure 1
Figure 1
Effect of PI and PS on immunogenicity of FVIII. A) The mean of total antibody titers (bars) and individual (closed circles) antibody titers against FVIII as determined by antibody capture ELISA in vWF mice immunized via i.v. administration of free FVIII, FVIII-PI, and FVIII-PS. B) The mean of inhibitory titers (bars) and individual (closed circles) antibody titers against FVIII as determined by the Nijmegen modification of the Bethesda assay in vWF knockout mice immunized via i.v. administration of free FVIII, FVIII-PI, FVIII-PS. C) Left panel shows the raw data for Thymidine (3H) incorporation (counts per minute) of different groups of splenocytes. The mean count (cross) and splenocytes from individual spleen (n=6) are shown (filled triangles). Typically negative group showed counts less than 300. Right panel shows the stimulation indices of different groups of splenocytes. The mean stimulation index (cross) and individual (filled circles) stimulation indices from individual spleens (n=6) of different treatment groups as determined by thymidine (3H) incorporation T cell proliferation assay.
Figure 1
Figure 1
Effect of PI and PS on immunogenicity of FVIII. A) The mean of total antibody titers (bars) and individual (closed circles) antibody titers against FVIII as determined by antibody capture ELISA in vWF mice immunized via i.v. administration of free FVIII, FVIII-PI, and FVIII-PS. B) The mean of inhibitory titers (bars) and individual (closed circles) antibody titers against FVIII as determined by the Nijmegen modification of the Bethesda assay in vWF knockout mice immunized via i.v. administration of free FVIII, FVIII-PI, FVIII-PS. C) Left panel shows the raw data for Thymidine (3H) incorporation (counts per minute) of different groups of splenocytes. The mean count (cross) and splenocytes from individual spleen (n=6) are shown (filled triangles). Typically negative group showed counts less than 300. Right panel shows the stimulation indices of different groups of splenocytes. The mean stimulation index (cross) and individual (filled circles) stimulation indices from individual spleens (n=6) of different treatment groups as determined by thymidine (3H) incorporation T cell proliferation assay.

Similar articles

Cited by

References

    1. Klinge J, Ananyeva NM, Hauser CA, et al. Hemophilia A--from basic science to clinical practice. Semin Thromb Hemost. 2002 Jun;28(3):309–322. - PubMed
    1. Pratt KP, Thompson AR. B-cell and T-cell epitopes in anti-factor VIII immune responses. Clin Rev Allergy Immunol. 2009 Oct;37(2):80–95. - PubMed
    1. Ananyeva NM, Lacroix-Desmazes S, Hauser CA, et al. Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives. Blood Coagul Fibrinolysis. 2004 Mar;15(2):109–124. - PubMed
    1. Jacquemin MG, Saint-Remy JM. Factor VIII immunogenicity. Haemophilia. 1998 Jul;4(4):552–557. - PubMed
    1. Skupsky J, Zhang AH, Su Y, et al. A role for thrombin in the initiation of the immune response to therapeutic factor VIII. Blood. 2009 Nov;114(21):4741–4748. - PMC - PubMed

Publication types

MeSH terms